We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Begins Phase 3 Trial of Olumiant for COVID-19 Patients
Eli Lilly Begins Phase 3 Trial of Olumiant for COVID-19 Patients
Eli Lilly has begun enrolling patients for a phase 3 trial of its rheumatoid arthritis treatment Olumiant (baricitinib) for hospitalized COVID-19 patients.